Tekla Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,473,710
Closed -$146M 218
2019
Q3
$146M Hold
1,473,710
6.38% 1
2019
Q2
$136M Hold
1,473,710
5.56% 1
2019
Q1
$139M Buy
1,473,710
+91,704
+7% +$8.02M 5.65% 1
2018
Q4
$88.6M Buy
1,382,006
+69,656
+5% +$5.14M 3.79% 6
2018
Q3
$117M Buy
1,312,350
+60,880
+5% +$5.38M 4.26% 5
2018
Q2
$99.4M Sell
1,251,470
-101,372
-7% -$8.42M 3.77% 6
2018
Q1
$121M Sell
1,352,842
-161,062
-11% -$15.5M 4.69% 2
2017
Q4
$158M Buy
1,513,904
+126,379
+9% +$14.3M 6.09% 2
2017
Q3
$202M Sell
1,387,525
-69,080
-5% -$9.41M 7.23% 2
2017
Q2
$189M Buy
1,456,605
+90,000
+7% +$11M 7.01% 1
2017
Q1
$170M Sell
1,366,605
-43,284
-3% -$5.18M 6.59% 2
2016
Q4
$163M Sell
1,409,889
-74,200
-5% -$8.26M 6.95% 2
2016
Q3
$155M Buy
1,484,089
+85,300
+6% +$9.23M 5.97% 2
2016
Q2
$138M Sell
1,398,789
-348,445
-20% -$36M 5.63% 2
2016
Q1
$175M Buy
1,747,234
+33,600
+2% +$3.46M 7.44% 2
2015
Q4
$205M Hold
1,713,634
7.44% 2
2015
Q3
$185M Sell
1,713,634
-215,600
-11% -$26.8M 6.66% 2
2015
Q2
$223M Sell
1,929,234
-65,600
-3% -$7.5M 8.08% 2
2015
Q1
$230M Hold
1,994,834
9.11% 1
2014
Q4
$223M Sell
1,994,834
-41,600
-2% -$4.39M 10.45% 1
2014
Q3
$193M Buy
2,036,434
+1,092,342
+116% +$98.6M 9.05% 2
2014
Q2
$81.1M Hold
944,092
7.44% 2
2014
Q1
$65.9M Sell
944,092
-76,000
-7% -$6.02M 6.59% 2
2013
Q4
$86.2M Hold
1,020,092
9.05% 2
2013
Q3
$78.5M Hold
1,020,092
8.74% 3
2013
Q2
$59.6M Buy
+1,020,092
New +$61.4M 8.11% 3

Other funds holding CELG

Tekla Capital Management's CELG Position: Q4 2019 in Review

Tekla Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,473,710 shares — an estimated $146M sold.

Tekla Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $230M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tekla Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tekla Capital Management sold 1,473,710 Celgene Corp shares in Q4 2019, an estimated $146M.
  • Tekla Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Tekla Capital Management's Celgene Corp position peaked at $230M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tekla Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.